105.5M shares $6.1M cash 5.7cps cash backing @ 7cps, that gives an EV of $1.3M Not bad for the degree of exposure to world class discovery and being fully funded for both stages, enabling an earn-in of the full 25%
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025